Geron
GERN
#6583
Rank
โ‚น77.72 B
Marketcap
โ‚น121.15
Share price
-1.54%
Change (1 day)
0.33%
Change (1 year)

EPS for Geron (GERN)

EPS in 2025 (TTM): -โ‚น11.43

According to Geron's latest financial reports the company's current EPS (TTM) is -โ‚น12.30. In 2024 the company made an earnings per share (EPS) of -โ‚น25.56 an increase over its 2023 EPS that were of -โ‚น31.23.

EPS history for Geron from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น11.43-55.27%
2024-โ‚น25.56-18.18%
2023-โ‚น31.23-8.33%
2022-โ‚น34.07-0%
2021-โ‚น34.0733.33%
2020-โ‚น25.56-25%
2019-โ‚น34.07140%
2018-โ‚น14.20-16.67%
2017-โ‚น17.04-0%
2016-โ‚น17.04-1.2970366926827E+18%
2015โ‚น0.0000000000-100%
2014-โ‚น22.72
2012-โ‚น51.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
โ‚น648.35-5,369.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น690.95-5,715.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น54.90 346.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น67.20-646.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,261 58,907.69%๐Ÿ‡บ๐Ÿ‡ธ USA